Q2 2026 Alignment Healthcare Inc Earnings Call Transcript
Key Points
- Alignment Healthcare Inc (ALHC) reported strong second-quarter 2026 results with health plan membership growing 31% year-over-year to 294,100 and total revenue increasing 32% to $1.3 billion.
- The company achieved its lowest medical benefit ratio (MBR) as a public company at 86.3%, a 40-basis-point improvement year-over-year, driven by its Care Anywhere clinical model and the deployment of its new AVA AI-powered stratification model.
- Adjusted EBITDA for Q2 2026 grew 48% year-over-year to $68 million, with a margin of 5.1%, representing 60 basis points of margin expansion, and first-half adjusted EBITDA of $106 million was up 60% versus the prior year.
- The embedded gross profit potential of the current membership has grown to approximately $880 million, up from a $600 million opportunity identified in early 2025, indicating significant future earnings growth from existing members.
- The company raised its full-year 2026 guidance for membership, revenue, and the low end of adjusted gross profit and adjusted EBITDA ranges, reflecting increased confidence in its full-year objectives.
- Adjusted SG&A as a percentage of revenue improved to 8.6% in Q2, a 20-basis-point improvement year-over-year, demonstrating operating leverage and efficiency in the business model.
- The company generated $111 million in operating cash flow in the first half of 2026 and ended the quarter with a strong liquidity position of $702 million in cash and short-term investments, with funded leverage improving to 2.2 times.
- Management expressed high confidence in its 2027 product strategy and the progress of its investments in scalability and portability, positioning the company for continued growth and expansion into new markets.
- The company guided for a seasonally higher MBR in the third quarter of 2026 due to planned investments in clinical operations (Care Anywhere), an earlier ramp of clinical hiring, and a flatter Part D expense slope, which will impact second-half profitability.
- The company expects only approximately 30% of its full-year adjusted EBITDA to be generated in the second half of 2026, a decrease from approximately 40% in the prior year, due to the timing of investments and a flatter Part D MBR.
- The company reported a $6.5 million unfavorable prior-year development in Q2 2026, which it chose to address by bolstering its reserves, indicating some pressure on prior-period claims costs.
- The final sweep pickup related to new members was smaller than the prior year on a per-member basis, partly due to the impact of the V28 risk adjustment model, which negatively affected the reported MBR.
- The company is making significant incremental investments in the second half of 2026, potentially in the double-digit millions, which will temper near-term earnings growth despite strong first-half performance.
- Management noted that approximately 50% of its members are still in their first or second year, which carries a higher MBR and represents a drag on current profitability until these cohorts mature.
- The company is facing a more competitive 2027 bidding environment, with management expecting one to three players to become more aggressive, which could pressure growth or margins.
- The company decided to stop providing detailed quarterly disclosure of its ADK (Acuity, Demographics, and Kronos) metric, citing that it creates noise and does not reflect the overall health of the operation, potentially reducing transparency for investors.
Good afternoon, and welcome to Alignment Healthcare second quarter 2026 earnings conference call and webcast. All participants will be in a listen-only mode. After todayâs presentation, there will be an opportunity to ask questions. To ask a question during the session, you will need to press star one one on your telephone. You would then hear an automated message advising your hand is raised. To withdraw your question, please press star one one again. We ask that you limit yourself to one question only. Please note that this event is being recorded. Leading todayâs call are John Kao, Chairman and CEO, and Tim Head, Chief Financial Officer. Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act.
These forward-looking statements are subject to various risks and uncertainties and reflect our current expectations based on our beliefs, assumptions, and information currently available to us. Descriptions of some of the factors that could cause actual results to differ
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
